Thus, combined inhibition of HSP90 and GRP75 was found to block Akt activation, facilitate p53 accumulation in the nuclei and activate growth-inhibitory target genes, ultimately reduce HCC tumor growth in vivo. Here, AKT1 is linked to neoplasm.